SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
MorphoSys AG's Partner OncoMed Pharmaceuticals, Inc. Advances the HuCAL Antibody OMP-59R5 Into Phase 1b/2 Clinical Trial in Pancreatic Cancer